Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,768 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00493714 | Delirium Recall in Advanced Cancer Patients | completed | — | 200 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00502580 | Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions | completed | — | 45 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00505024 | Interactive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic Surgery | completed | N/A | 100 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00505739 | Mifepristone for Patients With Endometrial Cancer and LGESS | completed | Phase 2 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00507585 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin | completed | Phase 1 | 63 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00508170 | Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection | completed | — | 252 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00508326 | Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement | completed | Phase 1 | 27 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00508807 | RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies | completed | Phase 1 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00514189 | Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines | terminated | Phase 1 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00527761 | Taxotere/Temodar/Cisplatin Study in Melanoma Patients | completed | Phase 1 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00529737 | Effect on Clip Markers After Vacuum-Assisted Biopsy by Postprocedure Mammogram | completed | N/A | 61 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00543153 | The Exceptional Patient in Cancer Care | completed | — | 13 | M.D. Anderson Cancer CenterOTHER | 2 | Jul 30, 2012 | clinicaltrials |
| NCT00632437 | Intraoperative Optical Imaging of Brain Function | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00811031 | Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 30, 2012 | clinicaltrials |
| NCT00838318 | Colon Cancer Screening in First-Degree Relatives of Hispanic Colorectal Cancer (CRC) Patients | completed | — | 26 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00849979 | Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy | completed | N/A | 184 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00877617 | Quality of Life in Men With High Risk Localized Prostate Cancer | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00897806 | Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer | terminated | — | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00903708 | LY2275796 in Advanced Cancer | completed | Phase 1 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00960726 | NOV-002 in Myelodysplastic Syndrome (MDS) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 30, 2012 | clinicaltrials |
| NCT01103388 | Rituximab Maintenance After Autologous Transplantation | terminated | Phase 3 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT01207635 | Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer | completed | — | 42 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00422032 | 2 Arm Study of Clofarabine IV in MDS Patients | completed | Phase 2 | 60 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 27, 2012 | clinicaltrials |
| NCT00806507 | Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients | completed | — | 45 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 23, 2012 | clinicaltrials |
| NCT00827801 | M. D. Anderson Symptom Inventory - Heart Failure (MDASI-HF) Symptom Management Program | completed | — | 26 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 23, 2012 | clinicaltrials |
| NCT01029509 | Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes | terminated | Phase 1 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 23, 2012 | clinicaltrials |
| NCT00038402 | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | completed | Phase 3 | 74 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT00488332 | An Exploratory Study on Optical Assessment of Oral Mucositis | terminated | — | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT00502502 | Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients | completed | — | 205 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT00893997 | PR1 Vaccination in Myelodysplastic Syndrome (MDS) | terminated | Phase 2 | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT00837239 | Huachansu & Gemcitabine in Pancreatic Cancer | completed | Phase 2 | 80 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00476294 | Long-Term Follow Up Study for AMD3100 Patients | completed | — | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00439361 | Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma | completed | Phase 1 | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 9, 2012 | clinicaltrials |
| NCT01333423 | Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC) | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jun 26, 2012 | clinicaltrials |
| NCT00494585 | CEP-701 for PH-negative Myelofibrosis | completed | Phase 2 | 27 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 25, 2012 | clinicaltrials |
| NCT00326170 | Phase II 5-Azacytidine Plus VPA Plus ATRA | completed | Phase 2 | 34 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 15, 2012 | clinicaltrials |
| NCT00427557 | Cellular Therapy With Cord Blood Cells | completed | Phase 2 | 31 | M.D. Anderson Cancer CenterOTHER | 1 | May 28, 2012 | clinicaltrials |
| NCT00502905 | Busulfan and Fludarabine in Patients With AML and MDS | completed | Phase 2 | 200 | M.D. Anderson Cancer CenterOTHER | 1 | May 28, 2012 | clinicaltrials |
| NCT00267046 | Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma | completed | Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | May 16, 2012 | clinicaltrials |
| NCT00412425 | Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting | completed | Phase 1 / Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | May 4, 2012 | clinicaltrials |
| NCT00499889 | Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients | terminated | Phase 2 | 42 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 23, 2012 | clinicaltrials |
| NCT00813254 | Cost Utility Analysis in Recurrent Ovarian Cancer | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT00505661 | Letrozole in Patients With Ovarian Tumors | terminated | Phase 2 | 16 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 18, 2012 | clinicaltrials |
| NCT00081861 | Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma | completed | Phase 2 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 5, 2012 | clinicaltrials |
| NCT00436657 | Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT00777686 | Measuring Non-Enhancing Glioblastoma Progression | completed | — | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 30, 2012 | clinicaltrials |
| NCT00828126 | PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma | completed | — | 38 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00500435 | Extraperitoneal Lymph Node Dissection in Patients With Cervical Cancer | completed | — | 65 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00503932 | Proton Therapy With Capecitabine for Rectal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT00965172 | Caphosol in Sarcoma Patients With Mucositis | completed | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 22, 2012 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials